New attack on advanced cancers: zapping tumors early to boost survival
NCT ID NCT03161522
Summary
This study is for people with esophageal or stomach cancer that has spread to only a few other places in the body. It compares two approaches: standard chemotherapy alone versus a more aggressive strategy that adds targeted radiation and possibly surgery to the chemotherapy. The goal is to see if attacking the main tumor and its few spread-out spots early can help patients live longer than just using drugs throughout the body.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC ADENOCARCINOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-••••
Contact
Conditions
Explore the condition pages connected to this study.